In an assessment of salmeterol we measured FIEy1
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anti-inflammatory dnrgs (n=55) 0*2 in 499 patients over 12 months. Not surprisingly, the 254 patients taking salmeterol showed an increase rather than a decrease in FEVy. In addition, the 245 control patients taking salbutamol 200 [tg also showed a rise (2 22 1 before the study and 2 44 1 at 12 months). Most of these patients, however, were receiving glucocorticosteroid treatment, which may have contributed to the result. We therefore examined the 55 patients treated with regular salbutamol who were not receiving anti-inflammatory drugs before randomisation; these also showed an increase in FEV, (figure).
Trhe difference between van Schayck and colleagues' results and our results may relate to the effect of stopping anti-inflammatory drugs. There were no apparent differences in the number of patients given anti-inflammatory treatment between the two groups studied by van Nurses do not often read medical records held separately, and simply telling the ward sister or charge nurse does not guarantee that information will be passed on to the next shift of nurses. The There are three rationales for issuing a "Do not resuscitate" order-cardiopulmonary resuscitation is ofno medical benefit; the current quality oflife is poor; and the quality of life after cardiopulmonary resuscitation is likely to be poor.3 In relation to the first rationale, "physicians have no obligation to provide, and patients and families have no right to demand, medical treatment that is of no demonstrable benefit."' Therefore, in those circumstances in which cardiopulmonary resuscitation will be of no benefit (most acute medical conditions barring conditions related to ischaemic heart disease) it is justified for a unilateral decision not to resuscitate to be made and documented in the notes.
The introduction of formal "Do not resuscitate" policies or of legislation relating to decisions not to resuscitate will not necessarily increase patients' autonomy or ensure that cardiopulmonary resuscitation is used more appropriately. In America, where "Do not resuscitate" policies are formal and are backed by legislation in many states, Kamer et al found that only 13-16% of acutely ill patients who died without being given cardiopulmonary resuscitation were consulted about the decision to withhold it. 4 Applebaum et al reported attempts at cardiopulmonary resuscitation in patients in whom rigor mortis had already set in-hardly an appropriate use of cardiopulmonary resuscitation, but one precipitated by formal, legally backed "Do not resuscitate" policies. 5 That guidelines for withholding cardiopulmonary resuscitation are required is not disputed. Ideally, patients or relatives should be consulted if cardiopulmonary resuscitation is to be withheld on grounds of poor quality of life, but the American approach to achieving this should be avoided at all costs. I await with interest the national guidance on this sensitive and difficult issue demanded by MPs from the chief medical officer.
